Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05197322Phase 2Recruiting

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Role: collaborator

NCT05414032Phase 2Recruiting

Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC

Role: collaborator

NCT06225505Not ApplicableRecruiting

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Role: collaborator

NCT05695976Suspended

GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM

Role: collaborator

NCT06230185Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Role: lead

NCT06705361Not ApplicableNot Yet Recruiting

Ice Bag, TR Band, and Air Compression Effects on Radial Line Removal Outcomes in Open Heart Surgery: A Clinical Trial

Role: collaborator

All 6 trials loaded